Actively Recruiting
The RADIANCE CED Study
Led by ReCor Medical, Inc. · Updated on 2026-01-09
1000
Participants Needed
1
Research Sites
318 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.
CONDITIONS
Official Title
The RADIANCE CED Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged �3e=65 years with uncontrolled hypertension
- Stable regimen of blood pressure-lowering medication
You will not qualify if you...
- Hypertension due to secondary causes
- Prior renal denervation treatment
- Pregnancy
- End-stage renal disease, dialysis, or kidney transplant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Henry Ford St. John Hospital
Detroit, Michigan, United States, 48236
Actively Recruiting
Research Team
H
Helen Reeve-Stoffer, Ph.D
CONTACT
E
Elizabeth A Sheehan, MLIS, MA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here